Cargando…
Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters
PURPOSE: To evaluate the safety and efficacy of transepithelial accelerated corneal crosslinking (CXL) for advanced keratoconus eyes with maximum keratometry (Kmax) values >58 diopters (D). SETTING: Department of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai, China. DESIGN: Pros...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845528/ https://www.ncbi.nlm.nih.gov/pubmed/34288636 http://dx.doi.org/10.1097/j.jcrs.0000000000000733 |
_version_ | 1784651690033545216 |
---|---|
author | Sun, Ling Zhao, Jing Zhang, Xiaoyu Shen, Yang Tian, Mi Zhou, Xingtao |
author_facet | Sun, Ling Zhao, Jing Zhang, Xiaoyu Shen, Yang Tian, Mi Zhou, Xingtao |
author_sort | Sun, Ling |
collection | PubMed |
description | PURPOSE: To evaluate the safety and efficacy of transepithelial accelerated corneal crosslinking (CXL) for advanced keratoconus eyes with maximum keratometry (Kmax) values >58 diopters (D). SETTING: Department of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai, China. DESIGN: Prospective parallel control study. METHODS: 41 keratoconus eyes from 41 patients (mean age, 21.93 ± 5.48 years) who underwent transepithelial accelerated CXL were included prospectively. The enrolled eyes were divided into 2 groups according to their Kmax values (Group A, Kmax ≥58.0 D; Group B, Kmax <58.0 D). The examinations including assessment of uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), corneal topography, and corneal endothelial cell density count were conducted preoperatively, at 1 day, 1 month, 3 months, 6 months, and 1 year postoperatively. RESULTS: All 41 eyes finished 1 year follow-up. No statistical difference was noted between the mean UDVA and CDVA in both groups throughout the follow-up duration. At 1-year postoperative follow-up, the CDVA increased by ≥2 lines in 45% (9/20) and 28.6% (6/21) eyes in Groups A and B, respectively. The mean preoperative Kmax in Groups A and B were 62.51 ± 3.34 D and 49.98 ± 4.32 D, respectively, and that at postoperative 1-year follow-up were 61.94 ± 4.11 D and 50.24 ± 4.72 D, respectively. The Kmax values of 30% (6/20) eyes in Group A and 4.8% (1/21) eyes in Group B decreased by more than 1 D. Deduction of flat K, steep K, mean K, and Kmax showed no significant difference between the 2 groups at 1-year postoperative follow-up. Moreover, 20% (4/20) and 23.8% (5/21) of eyes in Groups A and B, respectively, showed progress at postoperative 1-year follow-up. CONCLUSIONS: Transepithelial accelerated CXL can safely treat advanced keratoconus eyes with Kmax values ≥58.0 D with some extent of efficacy and has similar progressive rate as Kmax values <58.0 D. |
format | Online Article Text |
id | pubmed-8845528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer |
record_format | MEDLINE/PubMed |
spelling | pubmed-88455282022-02-24 Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters Sun, Ling Zhao, Jing Zhang, Xiaoyu Shen, Yang Tian, Mi Zhou, Xingtao J Cataract Refract Surg Articles PURPOSE: To evaluate the safety and efficacy of transepithelial accelerated corneal crosslinking (CXL) for advanced keratoconus eyes with maximum keratometry (Kmax) values >58 diopters (D). SETTING: Department of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai, China. DESIGN: Prospective parallel control study. METHODS: 41 keratoconus eyes from 41 patients (mean age, 21.93 ± 5.48 years) who underwent transepithelial accelerated CXL were included prospectively. The enrolled eyes were divided into 2 groups according to their Kmax values (Group A, Kmax ≥58.0 D; Group B, Kmax <58.0 D). The examinations including assessment of uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), corneal topography, and corneal endothelial cell density count were conducted preoperatively, at 1 day, 1 month, 3 months, 6 months, and 1 year postoperatively. RESULTS: All 41 eyes finished 1 year follow-up. No statistical difference was noted between the mean UDVA and CDVA in both groups throughout the follow-up duration. At 1-year postoperative follow-up, the CDVA increased by ≥2 lines in 45% (9/20) and 28.6% (6/21) eyes in Groups A and B, respectively. The mean preoperative Kmax in Groups A and B were 62.51 ± 3.34 D and 49.98 ± 4.32 D, respectively, and that at postoperative 1-year follow-up were 61.94 ± 4.11 D and 50.24 ± 4.72 D, respectively. The Kmax values of 30% (6/20) eyes in Group A and 4.8% (1/21) eyes in Group B decreased by more than 1 D. Deduction of flat K, steep K, mean K, and Kmax showed no significant difference between the 2 groups at 1-year postoperative follow-up. Moreover, 20% (4/20) and 23.8% (5/21) of eyes in Groups A and B, respectively, showed progress at postoperative 1-year follow-up. CONCLUSIONS: Transepithelial accelerated CXL can safely treat advanced keratoconus eyes with Kmax values ≥58.0 D with some extent of efficacy and has similar progressive rate as Kmax values <58.0 D. Wolters Kluwer 2022-02-01 2021-06-23 /pmc/articles/PMC8845528/ /pubmed/34288636 http://dx.doi.org/10.1097/j.jcrs.0000000000000733 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of ASCRS and ESCRS https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Articles Sun, Ling Zhao, Jing Zhang, Xiaoyu Shen, Yang Tian, Mi Zhou, Xingtao Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters |
title | Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters |
title_full | Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters |
title_fullStr | Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters |
title_full_unstemmed | Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters |
title_short | Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters |
title_sort | transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845528/ https://www.ncbi.nlm.nih.gov/pubmed/34288636 http://dx.doi.org/10.1097/j.jcrs.0000000000000733 |
work_keys_str_mv | AT sunling transepithelialacceleratedcornealcrosslinkingforkeratoconuseyeswithmaximumkeratometryvalueslargerthan58diopters AT zhaojing transepithelialacceleratedcornealcrosslinkingforkeratoconuseyeswithmaximumkeratometryvalueslargerthan58diopters AT zhangxiaoyu transepithelialacceleratedcornealcrosslinkingforkeratoconuseyeswithmaximumkeratometryvalueslargerthan58diopters AT shenyang transepithelialacceleratedcornealcrosslinkingforkeratoconuseyeswithmaximumkeratometryvalueslargerthan58diopters AT tianmi transepithelialacceleratedcornealcrosslinkingforkeratoconuseyeswithmaximumkeratometryvalueslargerthan58diopters AT zhouxingtao transepithelialacceleratedcornealcrosslinkingforkeratoconuseyeswithmaximumkeratometryvalueslargerthan58diopters |